检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈彦球[1] 葛怡琛[2] 徐培林[3] 杨燕[4]
机构地区:[1]中山大学第一附属医院,广东广州510008 [2]广东省职业病防治院毒理科,广东广州510275 [3]中山大学生命科学学院基因工程教育部重点实验室,广东广州510275 [4]中山大学公共卫生学院,广东广州510008
出 处:《细胞与分子免疫学杂志》2008年第10期962-965,共4页Chinese Journal of Cellular and Molecular Immunology
基 金:广东省自然科学基金博士启动资助项目(06300645);教育部博士点基金新教师资助项目(20070558275);中山大学2006学生业余科研项目(1163198);中山大学2007实验室开放基金项目(KF200707)
摘 要:目的:研究人核迁移蛋C(hNUDC)促进人脐血来源的CD34+细胞增殖、分化为巨核细胞的作用。方法:使用DynalCD34体外分离系统收集人脐血CD34+细胞,无血清甲基纤维素半固体法体外培养CD34+细胞12d后,显微镜下观察hNUDC对CD34+细胞分化增殖为小、中、大巨核细胞集落的形态、数目的影响;无血清液体培养体系培养CD34+细胞10d后,流式细胞术检测hNUDC对CD34+细胞分化增殖为CD41+细胞的表达率及其DNA倍性的影响。结果:hNUDC能够明显促进CD34+细胞分化增殖形成中小型CFU-MK集落,可显著增加巨核细胞表面标志物CD41+的表达,CD41+细胞中DNA倍性显著地高于血小板生成素。结论:hNUDC对促进造血干细胞增殖和分化为巨核细胞具有重要作用。AIM:To study the effect of human nuclear distribution C(hNUDC)on human megakaryocyte proliferation and differentiation from cord blood CD34+ cells in vitro.METHODS:Human CD34+ cells were isolated using the Dynal CD34 Progenitor Cell Selection System from umbilical cord blood.The CD34+ cells were then cultured in serum free methylcellulose semi-solid media,the morphologic aspects and number of small,medium and large CFU-MK colonies were observed and scored on the day12 by microscopy analysis.The CD34+ cells were cultured in serum free liquid media,cells were removed on day 10 and formation of CD41+ in human megakaryocyte and its DNA polyploidization of nuclear were analyzed on a FACsort flowcytometer.RESULTS:hNUDC supported the formation of small and medium CFU-MK colony in serum free semi-solid media.Furthermore,hNUDC induced a remarkable increase in expression of the megakaryocyte cell surface marker CD41+ and stimulated the CD41+ DNA polyploidization more effectively than TPO.CONCLUSION:hNUDC may play an important role in megakaryocyte proliferation and differentiation.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.249